Literature DB >> 21389992

Dreamboat sinks prospects for fast approval of inhaled insulin.

Jim Kling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21389992     DOI： 10.1038/nbt0311-175

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Plant biotechs defect.

Authors:  Susan Aldridge
Journal:  Nat Biotechnol       Date:  2008-03       Impact factor: 54.908

2.  Inhaled insulin's last gasp?

Authors:  Jim Kling
Journal:  Nat Biotechnol       Date:  2008-05       Impact factor: 54.908
  2 in total
  5 in total

Review 1.  Devices for dry powder drug delivery to the lung.

Authors:  Kai Berkenfeld; Alf Lamprecht; Jason T McConville
Journal:  AAPS PharmSciTech       Date:  2015-05-12       Impact factor: 3.246

2.  Sanofi to propel inhalable insulin Afrezza into market.

Authors:  Jim Kling
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908

Review 3.  An overview of clinical and commercial impact of drug delivery systems.

Authors:  Aaron C Anselmo; Samir Mitragotri
Journal:  J Control Release       Date:  2014-04-18       Impact factor: 9.776

4.  Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury.

Authors:  Simonetta Papa; Raffaele Ferrari; Massimiliano De Paola; Filippo Rossi; Alessandro Mariani; Ilaria Caron; Eliana Sammali; Marco Peviani; Valentina Dell'Oro; Claudio Colombo; Massimo Morbidelli; Gianluigi Forloni; Giuseppe Perale; Davide Moscatelli; Pietro Veglianese
Journal:  J Control Release       Date:  2013-11-10       Impact factor: 9.776

Review 5.  Inhaled insulin: A "puff" than a "shot" before meals.

Authors:  Dick B S Brashier; Anjan Khadka; Tejus Anantharamu; Ashok Kumar Sharma; A K Gupta; Sushil Sharma; N Dahiya
Journal:  J Pharmacol Pharmacother       Date:  2015 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.